Ken D’Entremont, Chief Executive Officer, Medexus Pharmaceuticals Inc., and his team joined Daniel Lubienietzky, Manager, Life Sciences, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.
July 7, 2021
· 1 min read